NEWS
View news from our Featured Companies.
Aytu BioPharma Announces Approval of the Cotempla XR-ODT® Manufacturing Site Transfer Prior Approval Supplement
U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to Contract ManufacturerUpon Completion of Manufacturing Transfer of Adzenys XR-ODT and Cotempla XR-ODT, Company Expects to Report Enhanced ADHD...
ChromaDex and Zesty Paws® Crack the Code on Cellular Health for Dogs With ‘Healthy Aging’ Line
The global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, ChromaDex, and the #1 selling pet supplement brand in the USA*, Zesty Paws®, debut cellular health supplement featuring ChromaDex's industry leading healthy aging...
ARIANNE PHOSPHATE AND ITS RESEARCH PARTNER RECEIVE A THREE-YEAR GRANT FOR THE DEVELOPMENT OF A PROMISING ORGANIC FERTILIZER
-additional funding will allow Cegep Riviere-de-Loup to continue work using high-purity phosphate in a new breed of fertilizer DAN: TSX-V (Canada) JE9N: FSE (Germany) DRRSF: OTCQX (USA) SAGUENAY, QC, Oct. 24, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne")...
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
Post-merger, the combined company, operating under the name "NAYA Biosciences", will be dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative medicineNAYA will seek to scale up profitable revenues in the...
Precision Optics Announces Receipt of $680,000 Production Order from Top Tier Defense/Aerospace Customer for New Optical Application
GARDNER, Mass., Oct. 19, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced $680,000 of initial production orders from a top...
Scientific Industries’ Bioprocessing Systems Operations (“SBI”) Unveils Expanded DOTS Platform Revolutionizing Shake Flask Bioprocessing
Multiparameter Sensor ("MPS") reader enables simultaneous monitoring of multiple critical parameters biomass or fluorescenceandDissolved Oxygen ("DO") Sensor Pills single-use chemosensors for online dissolved oxygen monitoring in real-timeBOHEMIA, NY / October 17,...
SenesTech Launches Evolve™ Soft Bait for Rodent Fertility Control
The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX, Oct. 17, 2023 -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and...
Kiora Pharmaceuticals to Participate in the Lytham Partners Fall 2023 Investor Conference
Encinitas, California--(October 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online presentation from the Lytham Partners Fall 2023 Investor Conference taking place on Tuesday October 17, 2023. As part of the presentation,...
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
SARASOTA, Fla., Oct. 11, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
Mogo to Participate in the Lytham Partners Fall 2023 Investor Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that it will be participating in the Lytham Partners Fall 2023 Investor Conference taking place...
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
PETACH TIKVA, Israel, Oct. 11, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") that...
Mogo Announces Multi-Year Deal with Oracle Cloud Infrastructure to Accelerate Growth of its Digital Wealth Platform
Migration to OCI will support scaling of Mogo's disruptive wealth offerings to Canadians VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that it has...
Zoomd to Participate in the Lytham Partners Fall 2023 Investor Conference
VANCOUVER, BC, Oct. 10, 2023 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, announced today...
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
ENGLEWOOD, CO / October 9, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, Chief Executive Officer, will present and host one-on-one meetings...
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference
PONTE VEDRA, Fla., Oct. 9, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
S&W Seed Company to Participate in the Lytham Partners Fall 2023 Investor Conference
LONGMONT, Colo., Oct. 9, 2023 -- S&W Seed Company (Nasdaq: SANW) announced today that Mark Herrmann, CEO, will be participating in a Company Webcast and Panel Presentation at the Lytham Partners Fall 2023 Investor Conference on Tuesday, October 17, 2023....
SenesTech to Participate in the Lytham Partners Fall 2023 Investor Conference
PHOENIX, Oct. 9, 2023 -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will present and host one-on-one meetings with investors at the Lytham Partners Fall 2023 Investor...
Precision Optics to Participate in the Lytham Partners Fall 2023 Investor Conference
GARDNER, Mass., Oct. 9, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will present...
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
PETACH TIKVA, Israel, Oct. 09, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that SHIELD I Phase 3 clinical data for D-PLEX100 will be highlighted in a presentation...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
PORTLAND, Maine, Oct. 05, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Mogo Announces 2023 Share Buybacks
Company has repurchased a total of 254,456 shares year to date VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that, during the three months ended...
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform
Safety Profile of D-PLEX100 and PLEX Platform Shown in Juvenile Animals for the First Time Results Could Support Clinical Evaluation of D-PLEX100 in Pediatric Population PETACH TIKVA, Israel, Oct. 04, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a...
Kiora Pharmaceuticals Receives Investigational New Drug Application Approval to Expand Phase 1b Study of KIO-301 in Inherited Retinal Diseases; To Enroll Patients with Choroideremia and Additional Patients with Late-Stage Retinitis Pigmentosa
Encinitas, California--(October 3, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has received Investigational New Drug Application approval in Australia to enroll up to six additional patients in the ABACUS study of KIO-301. ABACUS was initially designed to evaluate...
Greenfire Resources Ltd. Announces Appointment of New Chief Financial Officer
Calgary, Alberta--(October 2, 2023) - Greenfire Resources Ltd. (NYSE: GFR) ("Greenfire" or the "Company") a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta, Canada, is...
A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients
Celebrating a significant achievement in NAD+ research, these findings contribute to the mounting evidence indicating that NR may serve as a proactive safeguard against inflammatory cytokines in healthy adults and those with inflammation-related disorders LOS ANGELES...